Literature DB >> 16443131

Cerebral resuscitation: state of the art, experimental approaches and clinical perspectives.

Erik Popp1, Bernd W Böttiger.   

Abstract

Neuronal injury following global cerebral ischemia continues to bea central problem of patients in the postresuscitation phase following cardiocirculatory arrest. In addition to measures focusing on rapid restoration of spontaneous circulation, the most effective treatment after cardiac arrest, as shown by large randomized trials,is the use of therapeutic mild hypothermia. Current guidelines of the International Liaison Committee on Resuscitation (ILCOR)are recommending the use of therapeutic mild hypothermia for all unconscious patients after cardiac arrest. At present there is no specific neuroprotective treatment available. Promising animal experimental data concerning the use of thrombolytic agents during cardiopulmonary resuscitation have led to a large European multicenter trial (TROICA trial) that will provide its data in 2006.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443131     DOI: 10.1016/j.ncl.2005.10.008

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  12 in total

1.  [Saving lives with dispatcher-assisted resuscitation: importance of effective telephone instruction].

Authors:  C Kloppe; T Maaßen; U Bösader; C Hanefeld
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-11-05       Impact factor: 0.840

2.  The effect of granulocyte-colony stimulating factor in global cerebral ischemia in rats.

Authors:  Gerald A Matchett; Jason B Calinisan; Genoveve C Matchett; Robert D Martin; John H Zhang
Journal:  Brain Res       Date:  2007-01-08       Impact factor: 3.252

3.  Comparison of Quantitative Characteristics of Early Post-resuscitation EEG Between Asphyxial and Ventricular Fibrillation Cardiac Arrest in Rats.

Authors:  Bihua Chen; Gang Chen; Chenxi Dai; Pei Wang; Lei Zhang; Yuanyuan Huang; Yongqin Li
Journal:  Neurocrit Care       Date:  2018-04       Impact factor: 3.210

4.  The effect of 2-methoxyestradiol, a HIF-1 alpha inhibitor, in global cerebral ischemia in rats.

Authors:  Dachun Zhou; Gerald A Matchett; Vikram Jadhav; Neal Dach; John H Zhang
Journal:  Neurol Res       Date:  2007-08-22       Impact factor: 2.448

5.  Activation of liver X receptor reduces global ischemic brain injury by reduction of nuclear factor-kappaB.

Authors:  O Cheng; R P Ostrowski; W Liu; J H Zhang
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

Review 6.  Probing the molecular mechanisms of neuronal degeneration: importance of mitochondrial dysfunction and calcineurin activation.

Authors:  Hiroyuki Uchino; Yasuhiro Kuroda; Saori Morota; Go Hirabayashi; Nagao Ishii; Futoshi Shibasaki; Yukiho Ikeda; Magnus J Hansson; Eskil Elmér
Journal:  J Anesth       Date:  2008-08-07       Impact factor: 2.078

Review 7.  Management of brain injury after resuscitation from cardiac arrest.

Authors:  Romergryko G Geocadin; Matthew A Koenig; Xiaofeng Jia; Robert D Stevens; Mary Ann Peberdy
Journal:  Neurol Clin       Date:  2008-05       Impact factor: 3.806

8.  Palmitic acid methyl ester inhibits cardiac arrest-induced neuroinflammation and mitochondrial dysfunction.

Authors:  Celeste Yin-Chieh Wu; Alexandre Couto E Silva; Cristiane T Citadin; Garrett A Clemons; Christina H Acosta; Brianne A Knox; Mychal S Grames; Krista M Rodgers; Reggie Hui-Chao Lee; Hung Wen Lin
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2020-12-17       Impact factor: 4.006

9.  Expressional changes in cerebrovascular receptors after experimental transient forebrain ischemia.

Authors:  Sara Johansson; Gro Klitgaard Povlsen; Lars Edvinsson
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

10.  Number needed to treat = six: therapeutic hypothermia following cardiac arrest--an effective and cheap approach to save lives.

Authors:  Bernd W Böttiger; Andreas Schneider; Erik Popp
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.